David Krantz

3.3k total citations
78 papers, 1.9k citations indexed

About

David Krantz is a scholar working on Pediatrics, Perinatology and Child Health, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Krantz has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pediatrics, Perinatology and Child Health, 29 papers in Infectious Diseases and 22 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Krantz's work include Prenatal Screening and Diagnostics (59 papers), Parvovirus B19 Infection Studies (29 papers) and Pregnancy and preeclampsia studies (11 papers). David Krantz is often cited by papers focused on Prenatal Screening and Diagnostics (59 papers), Parvovirus B19 Infection Studies (29 papers) and Pregnancy and preeclampsia studies (11 papers). David Krantz collaborates with scholars based in United States, Italy and United Kingdom. David Krantz's co-authors include James N. Macri, Terrence Hallahan, John W. Larsen, F. Orlandi, Philip D. Buchanan, Eugene Pergament, Giovanni Damiani, Richard K. Silver, Ronald J. Wapner and Julia Zachary and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Cell Death and Differentiation and Clinical Chemistry.

In The Last Decade

David Krantz

74 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Krantz United States 21 1.5k 644 534 379 313 78 1.9k
Jonathan Hyett Australia 17 1.4k 0.9× 288 0.4× 1.0k 1.9× 335 0.9× 196 0.6× 43 1.9k
D. A. Luthy United States 19 928 0.6× 228 0.4× 618 1.2× 260 0.7× 232 0.7× 26 1.5k
Lin Wai Chan Hong Kong 22 885 0.6× 215 0.3× 497 0.9× 212 0.6× 185 0.6× 62 1.2k
L. Bussières France 22 1.1k 0.7× 336 0.5× 491 0.9× 171 0.5× 262 0.8× 75 1.6k
Corinne Hubinont Belgium 22 807 0.5× 173 0.3× 685 1.3× 322 0.8× 297 0.9× 91 1.7k
Ghalia Ashoor United Kingdom 15 1.2k 0.8× 522 0.8× 258 0.5× 102 0.3× 158 0.5× 22 1.4k
Tuangsit Wataganara Thailand 17 843 0.6× 134 0.2× 592 1.1× 140 0.4× 108 0.3× 76 1.1k
Jo‐Ann Brock Canada 14 681 0.4× 113 0.2× 281 0.5× 133 0.4× 197 0.6× 39 1.0k
Jo‐Ann Johnson Canada 20 885 0.6× 308 0.5× 85 0.2× 271 0.7× 158 0.5× 59 1.2k
Hyun Mee Ryu South Korea 19 739 0.5× 86 0.1× 504 0.9× 217 0.6× 147 0.5× 120 1.3k

Countries citing papers authored by David Krantz

Since Specialization
Citations

This map shows the geographic impact of David Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Krantz more than expected).

Fields of papers citing papers by David Krantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Krantz. The network helps show where David Krantz may publish in the future.

Co-authorship network of co-authors of David Krantz

This figure shows the co-authorship network connecting the top 25 collaborators of David Krantz. A scholar is included among the top collaborators of David Krantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Krantz. David Krantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krantz, David, et al.. (2025). Social Vulnerability and Pregnancy Option Counseling in the Setting of Periviable Delivery. Journal of Clinical Medicine. 14(2). 466–466. 1 indexed citations
2.
Hutton, Todd M., Scott T. Aaronson, Linda L. Carpenter, et al.. (2023). Dosing transcranial magnetic stimulation in major depressive disorder: Relations between number of treatment sessions and effectiveness in a large patient registry. Brain stimulation. 16(5). 1510–1521. 36 indexed citations
3.
Rochelson, Burton, et al.. (2020). Evaluation of Syndecan-1 as a Novel Biomarker for Adverse Pregnancy Outcomes. Reproductive Sciences. 27(1). 355–363. 12 indexed citations
4.
Gulersen, Moti, Michael Y. Divon, David Krantz, Frank A. Chervenak, & Eran Bornstein. (2019). The risk of spontaneous preterm birth in asymptomatic women with a short cervix (≤25 mm) at 23−28 weeks’ gestation. American Journal of Obstetrics & Gynecology MFM. 2(2). 100059–100059. 9 indexed citations
5.
Roman, Amanda, et al.. (2014). Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction. Prenatal Diagnosis. 34(7). 692–698. 14 indexed citations
6.
Molchadsky, Alina, Osnat Ezra, David Krantz, et al.. (2013). p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death and Differentiation. 20(5). 774–783. 93 indexed citations
7.
Krantz, David, Terrence Hallahan, & John Sherwin. (2010). Screening for Open Neural Tube Defects. Clinics in Laboratory Medicine. 30(3). 721–725. 14 indexed citations
8.
Chasen, Stephen T. & David Krantz. (2010). Does timing of biochemistry in first‐trimester aneuploidy risk assessment affect the gestational age at prenatal diagnosis and pregnancy termination?. Prenatal Diagnosis. 30(12-13). 1151–1154. 1 indexed citations
9.
Cleary‐Goldman, Jane, Andrei Rebarber, David Krantz, Terrence Hallahan, & Daniel H. Saltzman. (2008). First-trimester screening with nasal bone in twins. American Journal of Obstetrics and Gynecology. 199(3). 283.e1–283.e3. 16 indexed citations
10.
Norton, Mary E., et al.. (2007). First-trimester combined screening: experience with an instant results approach. American Journal of Obstetrics and Gynecology. 196(6). 606.e1–606.e5. 6 indexed citations
11.
Krantz, David, et al.. (2007). Genetic sonography after first‐trimester Down syndrome screening. Ultrasound in Obstetrics and Gynecology. 29(6). 666–670. 30 indexed citations
12.
Krantz, David, et al.. (2005). Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Prenatal Diagnosis. 25(8). 635–640. 36 indexed citations
13.
Orlandi, F., et al.. (2005). First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone. American Journal of Obstetrics and Gynecology. 192(4). 1107–1111. 35 indexed citations
14.
Goetzl, Laura, David Krantz, Joe Leigh Simpson, et al.. (2004). Pregnancy-Associated Plasma Protein A, Free β-hCG, Nuchal Translucency, and Risk of Pregnancy Loss. Obstetrics and Gynecology. 104(1). 30–36. 56 indexed citations
15.
Krantz, David, Laura Goetzl, Joe Leigh Simpson, et al.. (2004). Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology. 191(4). 1452–1458. 206 indexed citations
16.
Buchanan, Philip D., et al.. (2003). Combined first-trimester versus second-trimester serum screening for Down syndrome: A cost analysis. American Journal of Obstetrics and Gynecology. 188(3). 745–751. 17 indexed citations
17.
Hallahan, Terrence, David Krantz, F. Orlandi, et al.. (2000). First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG. Prenatal Diagnosis. 20(10). 785–789. 20 indexed citations
18.
Orlandi, F., et al.. (1997). First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound in Obstetrics and Gynecology. 10(6). 381–386. 97 indexed citations
19.
Macri, James N., et al.. (1990). Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin. American Journal of Obstetrics and Gynecology. 163(4). 1248–1253. 158 indexed citations
20.
Macri, James N., et al.. (1987). Maternal serum α-fetoprotein screening. American Journal of Obstetrics and Gynecology. 157(4). 820–822. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Hyett Breakdown of academic impact, for papers by D. A. Luthy Breakdown of academic impact, for papers by Lin Wai Chan Breakdown of academic impact, for papers by L. Bussières Breakdown of academic impact, for papers by Corinne Hubinont Breakdown of academic impact, for papers by Ghalia Ashoor Breakdown of academic impact, for papers by Tuangsit Wataganara Breakdown of academic impact, for papers by Jo‐Ann Brock Breakdown of academic impact, for papers by Jo‐Ann Johnson Breakdown of academic impact, for papers by Hyun Mee Ryu
Rankless by CCL
2026